Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
Public ClinicalTrials.gov record NCT01844115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD).
Study identification
- NCT ID
- NCT01844115
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 415 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013 (Actual)
- Primary completion
- Mar 31, 2014 (Actual)
- Completion
- Mar 31, 2014 (Actual)
- Last update posted
- Dec 18, 2019
2013 – 2014
United States locations
- U.S. sites
- 36
- U.S. states
- 16
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 023 | Birmingham | Alabama | 35216 | — |
| Forest Investigative Site 013 | Phoenix | Arizona | 85032 | — |
| Forest Investigative Site 036 | Beverly Hills | California | 90210 | — |
| Forest Investigative Site 001 | Costa Mesa | California | 92626 | — |
| Forest Investigative Site 009 | Oceanside | California | 92056 | — |
| Forest Investigative Site 026 | Rancho Mirage | California | 92270 | — |
| Forest Investigative Site 017 | Sherman Oaks | California | 91403 | — |
| Forest Investigative Site 034 | Sherman Oaks | California | 91403 | — |
| Forest Investigative Site 030 | Bradenton | Florida | 34201 | — |
| Forest Investigative Site 029 | Gainesville | Florida | 32607 | — |
| Forest Investigative Site 035 | Jacksonville | Florida | 32256 | — |
| Forest Investigative Site 032 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 021 | West Palm Beach | Florida | 33407 | — |
| Forest Investigative Site 025 | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site 018 | Decatur | Georgia | 30030 | — |
| Forest Investigative Site 022 | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative Site 014 | Berlin | New Jersey | 08009 | — |
| Forest Investigative Site 005 | Cherry Hill | New Jersey | 08002 | — |
| Forest Investigative Site 015 | Albuquerque | New Mexico | 87109 | — |
| Forest Investigative Site 028 | Brooklyn | New York | 11214 | — |
| Forest Investigative Site 010 | Brooklyn | New York | 11235 | — |
| Forest Investigative Site 002 | Cedarhurst | New York | 11516 | — |
| Forest Investigative Site 004 | Mount Kisco | New York | 10549 | — |
| Forest Investigative Site 003 | New York | New York | 10003 | — |
| Forest Investigative Site 007 | New York | New York | 10021 | — |
| Forest Investigative Site 020 | New York | New York | 10168 | — |
| Forest Investigative Site 027 | The Bronx | New York | 10467 | — |
| Forest Investigative Site 019 | Dayton | Ohio | 45417 | — |
| Forest Investigative Site 008 | Portland | Oregon | 97210 | — |
| Forest Investigative Site 037 | Allentown | Pennsylvania | 18104 | — |
| Forest Investigative Site 011 | Media | Pennsylvania | 19063 | — |
| Forest Investigative Site 033 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 031 | Dallas | Texas | 75231 | — |
| Forest Investigative Site 012 | Herndon | Virginia | 20170 | — |
| Forest Investigative Site 016 | Bellevue | Washington | 98007 | — |
| Forest Investigative Site 024 | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01844115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2019 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01844115 live on ClinicalTrials.gov.